According to a poll conducted by Curofy, 75 per cent of the surveyed doctors preferred digital interaction with pharma companies instead of a face-to-face to interaction with MRs. The result is in conformance with the fact that more doctors are adopting digital way to cater their professional needs.
Of the total 1,440 doctors who participated in the poll, an astounding 75 per cent (1,080) said they would prefer having drug information available at a convenient time on their fingertips over meeting MRs during OPD hours.
Earlier, the only way to spread drug launch information or new medical research information was through personal meetings and interactions. A medical representative has to visit a doctor a number of times to make him/her know about the new drug and ongoing research.
Often it happens that the doctor is not able to provide the representative with enough time, leading to wastage of time and money on both the ends. With the information available digitally, it becomes easier for doctors to comprehend the information with ease and at their own comfort level, the survey said.
MRs have been an integral part of the pharma industry since the very beginning. They help their company in reaching out a product to as many doctors as possible, Puri added.
Their work does not limit to inform doctors about the products, they also inform doctors about the ongoing researches in medicine. Even though it is an enlightening job, many doctors find it unpleasant to have MRs waiting in their lobby in the want of a chance to pounce on them for a meeting, he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
